(Q37212850)

19 August 2017

1 reference

title

Neurological findings in Hunter disease: pathology and possible therapeutic effects reviewed (English)

1 reference

19 August 2017

0 references

S Al Sawaf

1

1 reference

19 August 2017

E Mayatepek

series ordinal

2

1 reference

19 August 2017

B Hoffmann

series ordinal

3

1 reference

19 August 2017

publication date

13 July 2008

1 reference

Journal of Inherited Metabolic Disease

19 August 2017

published in

1 reference

19 August 2017

volume

31

1 reference

19 August 2017

issue

4

1 reference

19 August 2017

page(s)

473-480

1 reference

Electrophysiological and psychophysical findings in Hunter syndrome.

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10545-008-0878-X

Electroretinography and Fundus Oculi Findings in Hurler's Disease and Allied Mucopolysaccharidoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-008-0878-X

Multiple peripheral nerve entrapments. An unusual phenotypical variant of the Hunter syndrome (mucopolysaccharidosis II) in a family.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-008-0878-X

A clinical study of 77 patients with mucopolysaccharidosis type II

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-008-0878-X

Mucopolysaccharidosis type I, II, IIIA and V. Pathological and biochemical abnormalities in the neural and mesenchymal elements of the brain

21 January 2018

1 reference

12 December 2020

Chemical chaperones improve transport and enhance stability of mutant alpha-glucosidases in glycogen storage disease type II

1 reference

12 December 2020

Communicating hydrocephalus in children with genetic inborn errors of metabolism

1 reference

12 December 2020

Brain MRI findings in patients with mucopolysaccharidosis types I and II and mild clinical presentation.

1 reference

12 December 2020

Correlation between interleukin-6 promoter and C-reactive protein (CRP) polymorphisms and CRP levels with the Mainz Severity Score Index for Fabry disease

1 reference

12 December 2020

Ten years' experience of enzyme infusion therapy of Norrbottnian (type 3) Gaucher disease

1 reference

12 December 2020

Papilloedema in association with Hunter's syndrome

1 reference

12 December 2020

Intrathecal enzyme replacement therapy reduces lysosomal storage in the brain and meninges of the canine model of MPS I

1 reference

12 December 2020

Carpal tunnel syndrome in children with mucopolysaccaridoses

1 reference

12 December 2020

The otologic manifestations of mucopolysaccharidoses

1 reference

12 December 2020

Otologic and laryngologic manifestations of mucopolysaccharidoses after bone marrow transplantation

1 reference

12 December 2020

The natural history of the severe form of Hunter's syndrome: a study based on 52 cases.

1 reference

12 December 2020

Mild form of Hunter's syndrome: clinical delineation based on 31 cases

1 reference

12 December 2020

The clinical phenotype of two patients with a complete deletion of the iduronate-2-sulphatase gene (mucopolysaccharidosis II--Hunter syndrome)

1 reference

12 December 2020

Human mucopolysaccharidosis IIID: clinical, biochemical, morphological and immunohistochemical characteristics

1 reference

12 December 2020

Ultrastructural ocular pathology of Hunter's syndrome. Systemic mucopolysaccharidosis type II

1 reference

12 December 2020

Cytokines, neurotrophins, and oxidative stress in brain disease from mucopolysaccharidosis IIIB.

1 reference

12 December 2020

A Rare Disease in Two Brothers

1 reference

12 December 2020

Acute neuronopathic Gaucher disease complicated by fatal gastrointestinal bleeding

1 reference

12 December 2020

Airway obstruction and sleep apnea in Hurler and Hunter syndromes

1 reference

12 December 2020

Optic nerve head swelling and optic atrophy in the systemic mucopolysaccharidoses

1 reference

12 December 2020

Chemical chaperones increase the cellular activity of N370S beta -glucosidase: a therapeutic strategy for Gaucher disease

1 reference

12 December 2020

Increased cerebral blood flow velocity in children with mild sleep-disordered breathing: a possible association with abnormal neuropsychological function

1 reference

12 December 2020

Neurologic improvement in a type 3 Gaucher disease patient treated with imiglucerase/miglustat combination

1 reference

12 December 2020

Hunter syndrome: gene deletions and rearrangements

1 reference

12 December 2020

Elevated levels of dolichol in the brains of mucopolysaccharidosis and related disorders

1 reference

12 December 2020

Brain MRI in mucopolysaccharidosis: Effect of aging and correlation with biochemical findings

1 reference

12 December 2020

Evaluation of ADL in patients with Hunter disease using FIM score

1 reference

12 December 2020

Ocular histopathology in Hunter's syndrome. Systemic mucopolysaccharidosis type II

1 reference

12 December 2020

Evaluation of accumulated mucopolysaccharides in the brain of patients with mucopolysaccharidoses by (1)H-magnetic resonance spectroscopy before and after bone marrow transplantation

1 reference

12 December 2020

Hydrocephalus in Hunter Syndrome

1 reference

12 December 2020

Median nerve compression and trigger finger in the mucopolysaccharidoses and related diseases

1 reference

12 December 2020

The efficacy of enzyme replacement therapy in patients with chronic neuronopathic Gaucher's disease.

1 reference

12 December 2020

Molecular characterization of Portuguese patients with mucopolysaccharidosis type II shows evidence that the IDS gene is prone to splicing mutations

1 reference

12 December 2020

Severe type Hunter's syndrome. Polysomnographic and neuropathological study

1 reference

12 December 2020

Bilateral epiretinal membranes: a new finding in Hunter syndrome

1 reference

12 December 2020

A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome)

1 reference

12 December 2020

Activated microglia in cortex of mouse models of mucopolysaccharidoses I and IIIB

1 reference

12 December 2020

TNF-alpha levels and TNF-alpha gene polymorphism in type I Gaucher disease

1 reference

12 December 2020

Chemically modified beta-glucuronidase crosses blood-brain barrier and clears neuronal storage in murine mucopolysaccharidosis VII.

1 reference

12 December 2020

Enzyme replacement therapy in patients who have mucopolysaccharidosis I and are younger than 5 years: results of a multinational study of recombinant human alpha-L-iduronidase (laronidase).

1 reference

12 December 2020

Enzyme replacement therapy in two patients with an advanced severe (Hurler) phenotype of mucopolysaccharidosis I.

1 reference

12 December 2020

Myelopathy in mucopolysaccharidosis type II (Hunter syndrome).

1 reference

12 December 2020

The hand in mucopolysaccharide disorders

1 reference

12 December 2020

The Hunter syndrome in females: is there an autosomal recessive form of iduronate sulfatase deficiency?

1 reference

12 December 2020

Correlation of MR imaging and MR spectroscopy findings with cognitive impairment in mucopolysaccharidosis II.

1 reference

12 December 2020

Overcoming the blood-brain barrier with high-dose enzyme replacement therapy in murine mucopolysaccharidosis VII.

1 reference

12 December 2020

Compressive meningeal hypertrophy in mucopolysaccharidosis

1 reference

12 December 2020

The mucopolysaccharidoses: characterization by cranial MR imaging

1 reference

12 December 2020

Ocular manifestations and pathology of systemic mucopolysaccharidoses

1 reference

12 December 2020

Hunter syndrome presenting as macrocephaly and hydrocephalus

1 reference

12 December 2020

Adult obstructive sleep apnea: pathophysiology and diagnosis

1 reference

12 December 2020

Magnetic resonance imaging of the brain, neck and cervical spine in mild Hunter's syndrome (mucopolysaccharidoses type II).

1 reference

12 December 2020

Mucopolysaccharidosis type II in females: case report and review of literature.

1 reference

12 December 2020

Ocular changes in patients with mucopolysaccharidosis I receiving enzyme replacement therapy: a 4-year experience.

1 reference

12 December 2020

Epinephrine enhances lysosomal enzyme delivery across the blood brain barrier by up-regulation of the mannose 6-phosphate receptor

1 reference

12 December 2020

Intrathecal enzyme replacement therapy: successful treatment of brain disease via the cerebrospinal fluid

1 reference

12 December 2020

Hydrocephalus and shunt placement

1 reference

12 December 2020

Long-term follow-up following bone marrow transplantation for Hunter disease.

1 reference

12 December 2020

Pharmacological enhancement of beta-hexosaminidase activity in fibroblasts from adult Tay-Sachs and Sandhoff Patients.

1 reference

12 December 2020

Cerebral infarction in Hunter syndrome

1 reference

12 December 2020

10.1007/S10545-008-0878-X

Identifiers

DOI

1 reference

19 August 2017

1 reference